Why the Standard Life Aberdeen share price could smash the FTSE 100 this year

The prospects for Standard Life Aberdeen plc (LON: SLA) appear to be more positive than those of the FTSE 100 (INDEXFTSE: UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Having fallen by 14% since the start of the year, 2018 has not been a successful year for Standard Life Aberdeen (LSE: SLA) thus far. The company has experienced major disappointment through the loss of a large client, with investors seemingly becoming less certain about the merged entity’s future prospects.

Now though, the company seems to offer good value for money. Alongside its dividend growth potential, there seem to be clear catalysts to push its share price higher and allow it to outperform the FTSE 100. As such, it could be worth buying ahead of a number of shares that appear to be overvalued, such as one company that released results on Tuesday.

Positive outlook

The Standard Life Aberdeen share price has been hit hard by the loss of Lloyds as a customer. It announced a few months ago that it was ending the contract where around £109bn was managed by Standard Life Aberdeen. This is the company’s biggest contract and while it had been discussed as a potential risk following the merger (since Lloyds had the right to end the agreement in the instance of a merger), it was seen as unlikely by many investors.

The result of the loss of the contract was a major fall in the company’s share price which accounts for the majority of its decline since the start of the year. However, with a positive outlook for the global economy and world stock markets, demand for the company’s services could remain high. Investor sentiment has been positive in recent weeks, and this could help to improve its financial performance over the medium term.

Dividend potential

With Standard Life Aberdeen expected to grow its dividends per share by 6.6% per annum over the next two years, it seems to offer a solid income outlook. This could put it on a dividend yield of 6.7% in 2019, which could have significant appeal to a wide range of income investors. It may also signify that it offers good value for money at a time when the FTSE 100’s yield is 3.9%.

Of course, it’s not the only FTSE 100 stock with high dividend growth potential. Reporting on Tuesday was sales, marketing and support services company DCC (LSE: DCC). It also has a solid income outlook, but may now be overvalued after its 8% share price rise in the last month.

Margin of safety

DCC’s annual results showed that the company has been able to deliver strong performance across all of its divisions. Its total revenue increased by 12.6%, while adjusted operating profit moved 11.1% higher to £383.4m.

It completed acquisitions across all of its divisions, with £670m spent on M&A activity, which is the highest level of spend in its history. And with it having a successful track record of integrating new businesses, its strategy of expanding geographically through acquisition seems to be sound.

With DCC forecast to post a rise in dividends per share of 13.4% per year over the next two financial years, it is set to yield 2% in 2019 and could become increasingly attractive from an income perspective over the medium term. However, with it trading on a price-to-earnings (P/E) ratio of around 21 and forecast to post earnings growth of 5% next year, it may be overvalued.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Lloyds Banking Group and Standard Life Aberdeen. The Motley Fool UK has recommended Lloyds Banking Group and Standard Life Aberdeen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »